Confirmation of Intention to Float

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

This announcement is not a prospectus or admission document and not an offer of shares for sale in any jurisdiction, including in or into Australia, Canada, Japan, South Africa or the United States.

Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any shares referred to in this announcement except solely on the basis of the information contained in an Aquis Stock Exchange Growth Market admission document in its final form (together with any supplementary admission document, if relevant, the "Admission Document"), including the risk factors set out therein, that may be published by Voyager Life plc in connection with Admission (as defined below).

Voyager Life plc ("Voyager" or the "Company")

Confirmation of Intention to Float

CBD health and wellness company has applied for admission to Aquis Stock Exchange ("AQSE")

Perth, Scotland - Voyager, the health and wellness company established to supply high-quality Cannabidiol (CBD) and hemp seed oil products, has formally applied for admission to the Aquis Stock Exchange (AQSE) Growth Market (Access Segment) ("Admission"), as it prepares to open its first store and extend its product range.

Voyager was founded by chief executive Nick Tulloch in November 2020, to capitalise on the significant opportunity he believes exists due to the forecast growth and ongoing regulatory changes in the UK's CBD market, which is expected to surpass the value of the entire herbal supplements market and be worth more than £1bn by 2025.

The Company's application to AQSE is available at https://www.aquis.eu/aquis-stock-exchange/for-investors and the proposed Admission and associated placing will provide the Company with additional capital and a platform for future growth.  Once listed, Voyager shares will trade under the "ticker" VOY.

In February 2021, Voyager raised £874,000 through a crowdfunding campaign on Seedrs, and in April 2021 raised a further £741,000 through a private fundraise, including a commitment of £100,000 from Greencare Capital plc, the Aquis-listed investment company focused on medicinal cannabis and related areas.

Voyager has opened more than 20 new trading accounts with independent retail stores and chains in the last month, representing another potentially significant source of revenue for the firm which has, to date, relied largely on online sales through its own website (VoyagerCBD.com) and more than 20 third-party sites, including popular online platforms Amazon, eBay and Etsy.

The Company has also signed a lease on retail premises in St Andrews, the picturesque, historical university town on Scotland's east coast.  The shop, on the town's Market Street, is due to open by early July 2021 and is the Company's first foray into physical retail space, with the possibility of more shops to follow soon in other UK towns and cities if the Fife store proves successful as a means of showcasing and distributing its products to consumers and in raising brand awareness.

Voyager has a growing range of CBD and hemp seed oil products, including oils, 'gummies' for oral consumption, bath products and skincare products. In May 2021, Voyager added a Paw Balm to its increasingly popular pet range, which combines organic hemp seed oil and cooling aloe vera to soothe and relieve cracked paw pads and noses, and this week introduced eco-friendly hemp dog leads to further boost this range. In the coming weeks, Voyager plans to launch several new products within its core focus areas, in particular extending its bath care and sport ranges and, later in the summer, the Company has plans to bring its total product count to over 30 with the launch of a new skincare line.

Nick Tulloch, founder and chief executive of Voyager, said: "We are adopting a strictly professional approach to establishing the Company and developing our business. CBD is a fast-growing industry so it should be no surprise that it will attract increasing attention from regulators. Mainstream retailers will, rightly, only deal with fully compliant businesses, so the strict governance framework we have established as part of the fabric of Voyager is a key element of our approach. We are realistic and do not expect overnight success, but I am encouraged by the pace of growth we have achieved in the last six months, both in terms of new distribution channels and sales, which gives the board confidence that this is an ideal time for us to be taking Voyager to the stock market.

"We want Voyager to become the pre-eminent trusted CBD brand in the UK. We display laboratory reports on our website so customers can see exactly what it is they are buying. Furthermore, we include detailed information on all of our labels, in compliance with UK standards. With an experienced team and a product line created in preparation for the UK's new regulatory regime, we are well-placed to grow in tandem with the increasingly popular CBD health and wellness trend."

On 7 June 2021, the Company re-registered as a PLC as part of its final preparations to list on AQSE. Jill Overland and Nikki Cooper have joined Voyager as non-executive directors, bringing significant experience to the board chaired by Eric Boyle.

Retail investor participation in Voyager's IPO

Voyager raised investment from 295 crowdfunding investors via Seedrs earlier in 2021 and has worked with Seedrs to allow those investors to participate in Voyager's IPO. 

Nick Tulloch said: "IPOs have often excluded retail investors, but it was important to Voyager to recognise the support of the Seedrs investors and to find a way for them to participate. The Seedrs platform provides a solution to make this possible."

Kirsty Grant, Seedrs' Chief Investment Officer, said: "Seedrs is the only crowdfunding platform in the UK to have allowed retail investors access to IPOs and public company fundraises and we're delighted to be working again with Voyager to invite both the Company's existing investors and their followers into the IPO."

ENDS

The contents of this announcement, which has been prepared by and is the sole responsibility of the Company, have been approved by Cairn Financial Advisers LLP solely for the purposes of section 21(2)(b) of the Financial Services and Markets Act 2000, as amended.

Enquiries:

Voyager

Nick Tulloch - [email protected] / 01738 505 130

Charlotte Street Partners (financial communications)

David Gaffney - [email protected] / +44 (0) 7854 609 998

Andrew Wilson - [email protected] / +44 (0)7810 636 995

Website and social media links:

https://voyagerlife.uk 

https://voyagercbd.com/ 

https://www.instagram.com/voyagercbd/ 

https://twitter.com/voyagercbd 

https://www.linkedin.com/company/voyager-cbd/ 

https://www.facebook.com/VoyagerCBD/  

IMPORTANT NOTICES AND DISCLAIMER

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed by any person for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

This announcement (the "Announcement") and the information contained in it is not for publication, release, transmission, distribution or forwarding, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction in which publication, release or distribution would be unlawful. This Announcement is for information purposes only and does not constitute an offer to sell or issue, or the solicitation of an offer to buy, acquire or subscribe for shares in the capital of the Company in the United Kingdom, the United States, Australia, Canada, Japan or the Republic of South Africa or any other state or jurisdiction. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.  This Announcement has not been approved by Aquis Exchange PLC or by any other securities exchange. 

The ordinary shares in the capital of the Company ("Ordinary Shares") have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold, pledged, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, in or into the United States absent registration under the Securities Act, except pursuant to an exemption from the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States.  Such Ordinary Shares have not been approved, disapproved or recommended by the U.S. Securities and Exchange Commission, any state securities commission in the United States or any other U.S. regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of any offering of Ordinary Shares. Subject to certain exceptions, the securities referred to herein may not be offered or sold in the United States, Australia, Canada, Japan or the Republic of South Africa or to, or for the account or benefit of, any national, resident or citizen of the United States, Australia, Canada, Japan or the Republic of South Africa. No public offering of Ordinary Shares is being made in the United Kingdom, the United States or elsewhere.

Cairn Financial Advisers LLP ("Cairn"), which is authorised and regulated by the Financial Conduct Authority for the conduct of regulated activities in the United Kingdom, is acting as Corporate Adviser to the Company and no one else in connection with Admission and is not acting for and will not be responsible to any person other than the Company for providing the protections afforded to its clients or for providing advice in relation to Admission.

Bixteth Partners Limited ("Bixteth"), an appointed representative of Messels Ltd which is authorised and regulated by the Financial Conduct Authority for the conduct of regulated activities in the United Kingdom, is acting as advisor to the Company and no one else in connection with Admission and is not acting for and will not be responsible to any person other than the Company for providing the protections afforded to its clients or for providing advice in relation to Admission.

This Announcement contains (or may contain) certain forward-looking statements with respect to certain of the Company's current expectations and projections about future events. These statements, which sometimes use words such as "aim", "anticipate", "believe", "intend", "plan", "estimate", "expect" and words of similar meaning, reflect the directors' beliefs and expectations and involve a number of risks, uncertainties and assumptions which may occur in the future, are beyond the Company's control and could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statement. Statements contained in this Announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The information contained in this Announcement is subject to change without notice and, except as required by applicable law, the Company does not assume any responsibility or obligation to update publicly or review any of the forward-looking statements contained in it, nor does it intend to. As a result of these risks, uncertainties and assumptions, no-one should place undue reliance on these forward-looking statements as a prediction of actual results or otherwise.

This Announcement does not identify or suggest, or purport to identify or suggest, the risks (direct or indirect) that may be associated with an investment in the Company. Any investment decision to subscribe for Ordinary Shares in the Company must be made solely on the basis of the Admission Document, if published.

This Announcement does not constitute a recommendation concerning any investor's options with respect to the Ordinary Shares. Any investor or prospective investor should conduct his, her or its own investigation, analysis and evaluation of the business and data described in the Admission Document if, as and when it is published by the Company. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. 

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this Announcement.